← Open Payments lookup

BRIGITTE SHAFFER: Open Payments

NPI 1407352594 · HOUSTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$239 in 11 payments from 7 companies in 2025. Trend: 2023 $77 · 2024 $82 · 2025 $239

Food & beverage: $239
CompanyPaymentsAmount
Novo Nordisk Inc2$66
Otsuka America Pharmaceutical, Inc.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Janssen Pharmaceuticals, Inc1$24
Verona Pharma, Inc.1$16
Travere Therapeutics, Inc.1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: Ozempic, CAPLYTA, REXULTI, SPRAVATO, JYNARQUE, VOYXACT, Ohtuvayre, JARDIANCE.

Industry payments across MO — which companies pay providers there.